首页> 外文期刊>Pain medicine : >A Multicenter, Prospective, Randomized, Placebo-Controlled, Double-Blind Study of a Novel Pain Management Device, AT-02, in Patients with Fibromyalgia
【24h】

A Multicenter, Prospective, Randomized, Placebo-Controlled, Double-Blind Study of a Novel Pain Management Device, AT-02, in Patients with Fibromyalgia

机译:一种多中心,前瞻性,随机,安慰剂对照,对纤维肌痛患者的新型疼痛管理装置的双盲研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives Existing treatments for fibromyalgia have limited efficacy, and only a minority of individuals clinically respond to any single intervention. This study was a prospective, multicenter, randomized, double-blind, controlled clinical trial to evaluate the feasibility of alternating magnetic field therapy in fibromyalgia patients by comparing the Angel Touch device (AT-02) with a sham control (S-01).
机译:目的对纤维肌痛的现有治疗有限,尤为少数个体临床上响应任何单一干预。 本研究是一种前瞻性,多中心,随机的双盲,受控临床试验,以评估通过将天使触摸装置(AT-02)与假控制(S-01)进行比较来评估纤维脑痛患者交替磁场治疗的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号